Detailed Information
Cited 2 time in 
Cited 2 time in 
Cited 2 time in
Metadata Downloads
In vitro activity of ceftazidime-avibactam and comparators against bacterial isolates collected in South Korea as part of the ATLAS global surveillance program (2016-2018)
- Authors
- Bae, In-Gyu; Stone, Gregory G.
- Issue Date
- Jan-2022
- Publisher
- Elsevier BV
- Keywords
- ATLAS; ceftazidime-avibactam; Enterobacterales; Pseudomonas aeruginosa; South Korea; surveillance
- Citation
- Diagnostic Microbiology and Infectious Disease, v.102, no.1
- Indexed
- SCIE
SCOPUS
- Journal Title
- Diagnostic Microbiology and Infectious Disease
- Volume
- 102
- Number
- 1
- ISSN
- 0732-8893
1879-0070
- Abstract
- Overall, 1,277 Enterobacterales and 296 P. aeruginosa isolates were collected in South Korea between 2016 and 2018. Rates of susceptibility were >95% to ceftazidime-avibactam, tigecycline, meropenem and amikacin among the Enterobacterales and of the P. aeruginosa collected, 92.9% were susceptibility to amikacin and 92.6% to ceftazidime-avibactam. (c) 2021 The Authors. Published by Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.